LifeSci Acquisition II Corp. (LSAQ)
| Market Cap | 94.69M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 9.38M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | April 19 |
| Last Price | $10.10 |
| Previous Close | $10.11 |
| Change ($) | -0.01 |
| Change (%) | -0.10% |
| Day's Open | 10.17 |
| Day's Range | 10.06 - 10.13 |
| Day's Volume | 440 |
| 52-Week Range | 9.77 - 12.68 |
News
NEW YORK, Nov. 20, 2020 (GLOBE NEWSWIRE) -- LifeSci Acquisition II Corp. (NASDAQ: LSAQ), a blank check company targeting the biopharma sector, announced today that it priced its initial public offering ...
About LSAQ
LifeSci Acquisition II Corp. is a blank check company formed under the laws of the State of Delaware on December 18, 2019. We were formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Although there is no restriction or limitation on what industry our target operates in, it is our intention to pursue prospective targets that are focused on healthcare innovation. We anticipate targeting companies domiciled in North America or E... [Read more...]
| Industry Shell Companies | IPO Date Nov 20, 2020 |
| CEO Andrew McDonald | Country United States |
| Stock Exchange NASDAQ | Ticker Symbol LSAQ |